<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Laudisi F</submitter><funding>Ministero dell'Università e della Ricerca</funding><pagination>18</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12914907</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(1)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Defects of the gut epithelial barrier and counter-regulatory mechanisms are a prerequisite for the onset of intestinal inflammation in patients with inflammatory bowel diseases (IBD). Elevated levels of Smad7, an inhibitor of TGF-β1, in both epithelial and immune cells have been associated with the pathological processes observed in IBD. We aim to determine the relevance of Smad7 expression in the epithelial compartment.&lt;h4>Methods&lt;/h4>We generated mice overexpressing Smad7 in the gut epithelium (Smad7TgCre&lt;sup>+&lt;/sup>) and monitored pathology development. Inflammatory cell infiltration was assessed using multiplex immunofluorescence and flow cytometry. To investigate the molecular mechanisms underlying ileal damage, we performed spatial transcriptomics on froze</pubmed_abstract><journal>Journal of biomedical science</journal><pubmed_title>Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation.</pubmed_title><pmcid>PMC12914907</pmcid><funding_grant_id>PNRR M4C2I1.3 PE6 project PE00000019 Heal Italia</funding_grant_id><funding_grant_id>PRIN 2022JEBP88,</funding_grant_id><pubmed_authors>Villablanca EJ</pubmed_authors><pubmed_authors>Stolfi C</pubmed_authors><pubmed_authors>Zorzi F</pubmed_authors><pubmed_authors>He N</pubmed_authors><pubmed_authors>Sica GS</pubmed_authors><pubmed_authors>Melaiu O</pubmed_authors><pubmed_authors>Monasterio G</pubmed_authors><pubmed_authors>Sommella EM</pubmed_authors><pubmed_authors>Fantini MC</pubmed_authors><pubmed_authors>Pacifico T</pubmed_authors><pubmed_authors>Monteleone I</pubmed_authors><pubmed_authors>Serra MA</pubmed_authors><pubmed_authors>Tomassini L</pubmed_authors><pubmed_authors>Ortenzi A</pubmed_authors><pubmed_authors>D'Oria V</pubmed_authors><pubmed_authors>Monteleone G</pubmed_authors><pubmed_authors>Laudisi F</pubmed_authors><pubmed_authors>De Stefanis C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation.</name><description>&lt;h4>Background and aims&lt;/h4>Defects of the gut epithelial barrier and counter-regulatory mechanisms are a prerequisite for the onset of intestinal inflammation in patients with inflammatory bowel diseases (IBD). Elevated levels of Smad7, an inhibitor of TGF-β1, in both epithelial and immune cells have been associated with the pathological processes observed in IBD. We aim to determine the relevance of Smad7 expression in the epithelial compartment.&lt;h4>Methods&lt;/h4>We generated mice overexpressing Smad7 in the gut epithelium (Smad7TgCre&lt;sup>+&lt;/sup>) and monitored pathology development. Inflammatory cell infiltration was assessed using multiplex immunofluorescence and flow cytometry. To investigate the molecular mechanisms underlying ileal damage, we performed spatial transcriptomics on froze</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T06:30:55.512Z</modification><creation>2026-07-09T10:39:09.506Z</creation></dates><accession>S-EPMC12914907</accession><cross_references><pubmed>41703574</pubmed><doi>10.1186/s12929-026-01224-3</doi></cross_references></HashMap>